SM
PBM icon

Sabby Management’s Psyence Biomedical PBM Stock Holding History

Sabby Management’s Portfolio PBM Stock Details PBM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,252
Closed -$108K – 63
2025
Q2 		$108K Sell
3,252
-1,901
-37% -$52.6K 0.2% 33
2025
Q1 		$154K Buy
+5,153
New +$328K 0.45% 29

Other funds holding PBM

PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return

Sabby Management's PBM Position: Q3 2025 in Review

Sabby Management sold out of Psyence Biomedical (PBM) in Q3 2025, closing a stake of 3,252 shares — an estimated $108K sold.

Sabby Management first reported a position in PBM in Q1 2025 and held it in 2 quarters. The position peaked at $154K in Q1 2025. 6 funds tracked by Wall St. Rank hold PBM as of Q3 2025.

  • Sabby Management reported no remaining Psyence Biomedical position as of Q3 2025 after selling out during the quarter.
  • Sabby Management sold 3,252 Psyence Biomedical shares in Q3 2025, an estimated $108K.
  • Sabby Management first reported a position in Psyence Biomedical in Q1 2025 and held it in 2 quarters.
  • Sabby Management's Psyence Biomedical position peaked at $154K in Q1 2025.
  • 6 funds tracked by Wall St. Rank held Psyence Biomedical as of Q3 2025.

Based on Sabby Management's 13F filing for Q3 2025, filed 14 Nov 2025.